408 related articles for article (PubMed ID: 17010038)
1. Persistence of rabbit haemorrhagic disease virus genome in vaccinated rabbits after experimental infection.
Gall A; Schirrmeier H
J Vet Med B Infect Dis Vet Public Health; 2006 Oct; 53(8):358-62. PubMed ID: 17010038
[TBL] [Abstract][Full Text] [Related]
2. Persistence of viral RNA in rabbits which overcome an experimental RHDV infection detected by a highly sensitive multiplex real-time RT-PCR.
Gall A; Hoffmann B; Teifke JP; Lange B; Schirrmeier H
Vet Microbiol; 2007 Feb; 120(1-2):17-32. PubMed ID: 17112688
[TBL] [Abstract][Full Text] [Related]
3. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
[TBL] [Abstract][Full Text] [Related]
4. Serological evidence for a non-protective RHDV-like virus.
Marchandeau S; Le Gall-Reculé G; Bertagnoli S; Aubineau J; Botti G; Lavazza A
Vet Res; 2005; 36(1):53-62. PubMed ID: 15610723
[TBL] [Abstract][Full Text] [Related]
5. Benign circulation of rabbit haemorrhagic disease virus on Lambay Island, Eire.
Forrester NL; Trout RC; Gould EA
Virology; 2007 Feb; 358(1):18-22. PubMed ID: 17049958
[TBL] [Abstract][Full Text] [Related]
6. A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV).
Rohde J; Schirrmeier H; Granzow H; Rziha HJ
Vaccine; 2011 Nov; 29(49):9256-64. PubMed ID: 22001119
[TBL] [Abstract][Full Text] [Related]
7. The recombinant rabbit hemorrhagic disease virus VP60 protein obtained from Pichia pastoris induces a strong humoral and cell-mediated immune response following intranasal immunization in mice.
Farnós O; Rodríguez M; Chiong M; Parra F; Boué O; Lorenzo N; Colás M; Lleonart R
Vet Microbiol; 2006 May; 114(3-4):187-95. PubMed ID: 16384666
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-based oral vaccine for rabbit hemorrhagic disease.
Wang X; Qiu L; Hao H; Zhang W; Fu X; Zhang H; He S; Zhang S; Du E; Yang Z
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):277-82. PubMed ID: 22154735
[TBL] [Abstract][Full Text] [Related]
9. Distribution of rabbit haemorrhagic disease virus RNA in experimentally infected rabbits.
Kimura T; Mitsui I; Okada Y; Furuya T; Ochiai K; Umemura T; Itakura C
J Comp Pathol; 2001; 124(2-3):134-41. PubMed ID: 11222010
[TBL] [Abstract][Full Text] [Related]
10. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.
Spibey N; McCabe VJ; Greenwood NM; Jack SC; Sutton D; van der Waart L
Vet Rec; 2012 Mar; 170(12):309. PubMed ID: 22266680
[TBL] [Abstract][Full Text] [Related]
11. Experimental infections of rabbits with rabbit haemorrhagic disease virus monitored by polymerase chain reaction.
Shien JH; Shieh HK; Lee LH
Res Vet Sci; 2000 Jun; 68(3):255-9. PubMed ID: 10877972
[TBL] [Abstract][Full Text] [Related]
12. Protective immune responses in rabbits induced by a suicidal DNA vaccine of the VP60 gene of rabbit hemorrhagic disease virus.
Cheng Y; Chen Z; Li C; Meng C; Wu R; Liu G
Antiviral Res; 2013 Mar; 97(3):227-31. PubMed ID: 23295353
[TBL] [Abstract][Full Text] [Related]
13. Adult rabbits acquire resistance to lethal calicivirus infection by adoptive transfer of sera from infected young rabbits.
Ferreira PG; Dinís M; Costa-E-Silva A; Aguas AP
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):364-9. PubMed ID: 17980918
[TBL] [Abstract][Full Text] [Related]
14. A serial cross-sectional study of the prevalence of rabbit haemorrhagic disease on three farms in the lower North Island of New Zealand.
Henning J; Davies P
N Z Vet J; 2005 Apr; 53(2):149-53. PubMed ID: 15846400
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: advantages for immunization strategies and vaccine implementation.
Farnós O; Fernández E; Chiong M; Parra F; Joglar M; Méndez L; Rodríguez E; Moya G; Rodríguez D; Lleonart R; González EM; Alonso A; Alfonso P; Suárez M; Rodríguez MP; Toledo JR
Antiviral Res; 2009 Jan; 81(1):25-36. PubMed ID: 18824033
[TBL] [Abstract][Full Text] [Related]
16. Subacute liver necrosis after experimental infection with rabbit haemorrhagic disease virus (RHDV).
Teifke JP; Reimann I; Schirrmeier H
J Comp Pathol; 2002; 126(2-3):231-4. PubMed ID: 11945014
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of piglets to rabbit hemorrhagic disease virus following experimental infection.
Shien JH; Lee LH
Can J Vet Res; 2000 Apr; 64(2):134-7. PubMed ID: 10805254
[TBL] [Abstract][Full Text] [Related]
18. Egg yolk IgY against RHDV capsid protein VP60 promotes rabbit defense against RHDV infection.
Li ZX; Hu WD; Li BC; Li TY; Zhou XY; Zhang Z
Vet Immunol Immunopathol; 2014 Jan; 157(1-2):97-104. PubMed ID: 24252247
[TBL] [Abstract][Full Text] [Related]
19. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.
Pérez-Filgueira DM; Resino-Talaván P; Cubillos C; Angulo I; Barderas MG; Barcena J; Escribano JM
Virology; 2007 Aug; 364(2):422-30. PubMed ID: 17434554
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of attenuated Salmonella typhimurium containing a DNA vaccine against rabbit haemorrhagic disease.
Qiu L; Wang X; Hao H; Mu G; Dang R; Wang J; Zhang S; Du E; Yang Z
J Virol Methods; 2013 Mar; 188(1-2):108-13. PubMed ID: 23270916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
